« Zurück
Startseite /
MAPK14 Antibody (T180/Y182) Blocking Peptide

MAPK14 Antibody (T180/Y182) Blocking Peptide

ArtNr	ABC-BP7226f
Hersteller	Abcepta
Menge	500 ug
Kategorie	Peptides & Proteins Peptides
Typ	Peptides
Format	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Similar products	MAPK14, Mitogen-activated protein kinase 14, Mitogen-activated protein kinase p38 alpha, CSBP, CSBP1, CSBP2, CSPB1, SAPK2A, MAX-interacting protein 2, MAP kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-binding protein, CSAID-binding protein, MAP kinase MXI2, MAP kinase p38 alpha, Stress-activated protein kinase 2a, MXI2, SAPK2a
Lieferbar
Primary Accession	Q16539
Bio Background	MAPK14 is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response.
Bio References	Cheung, P.C., et al., EMBO J. 22(21):5793-5805 (2003).Dean, J.L., et al., J. Biol. Chem. 278(41):39470-39476 (2003).Sun, A., et al., Exp. Neurol. 183(2):394-405 (2003).Yustein, J.T., et al., Oncogene 22(40):6129-6141 (2003).Frevel, M.A., et al., Mol. Cell. Biol. 23(2):425-436 (2003).
Gene ID	1432
Gene Name	MAPK14
Subtitle	Synthetic peptide
Target/Specificity	The synthetic peptide sequence used to generate the antibody AP7226f was selected from the T180/Y182 region of human MAPK14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

ABC-BP7226f-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 500 ug

lieferbar

Lieferung vsl. bis 02.10.2025

Express-Lieferung: 15 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern